Last A$0.85 AUD
Change Today +0.05 / 6.25%
Volume 6.5K
PGL On Other Exchanges
Symbol
Exchange
OTC US
Frankfurt
As of 1:56 AM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael Fitzgerald ADN MSN

Director of Clinical Operations - US, Progen Pharmaceuticals Limited
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

----

Background*

Mr. Michael Fitzgerald, ADN, MSN serves as the Director of Clinical Operations - US at Progen Pharmaceuticals Limited.

Corporate Headquarters*

2806 Ipswich Road
Darra, Queensland 4076

Australia

Phone: 61 7 3273 9133
Fax: 61 7 3375 1168

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGL:AU A$0.85 AUD +0.05

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGEN PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.